PMID: 6397784Jan 1, 1984Paper

Hepatic drug metabolism in pregnancy

Quarterly Reviews on Drug Metabolism and Drug Interactions
B H Stock

Abstract

The results of both isolated tissue and whole animal experimentation, whilst showing some unexplored inconsistencies, suggest that late pregnancy is associated with a reduced ability of the liver to metabolise foreign compounds. The mechanism of this reduced capacity and the physiological reason for it are unclear but such change does have implication for therapeutic response in pregnancy. Available results from the limited and often poorly structured studies of drug levels in pregnant women neither prove nor disprove the existence of similar changes in hepatic monooxygenase activity during human pregnancy.

References

Apr 17, 1979·European Journal of Clinical Pharmacology·E ReyG Olive
Aug 15, 1977·Biochemical Pharmacology·G FeuerR Farkas
Jul 1, 1979·Clinical Pharmacokinetics·A Philipson
Jan 1, 1979·Clinical Pharmacokinetics·M DamK I Mygind
Feb 1, 1977·Neurology·C M LanderJ H Tyrer
Nov 1, 1977·Clinical Pharmacokinetics·M J EadieJ H Tyrer
Mar 1, 1978·Clinical Pharmacology and Therapeutics·D MorganE Triggs
Mar 15, 1978·Biochemical and Biophysical Research Communications·H MukhtarJ R Bend
Jun 19, 1978·European Journal of Clinical Pharmacology·R G Moore, W G McBride
Jan 1, 1979·Clinical Pharmacology and Therapeutics·G TomsonA Rane
Aug 1, 1976·Acta Neurologica Scandinavica·K I MygindJ Christiansen
Oct 1, 1977·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P R McElhattonP A Toseland
Jan 30, 1976·Archives of Toxicology·I GutM Gutová
Dec 1, 1975·Canadian Journal of Physiology and Pharmacology·J U BellD J Ecobichon
Jan 1, 1966·Acta Physiologica Scandinavica·M O Pulkkinen
Feb 26, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·E Schlede, R Borowski
Jun 15, 1973·Biochemical Pharmacology·M G Neale, D V Parke
Jan 1, 1982·Therapeutic Drug Monitoring·P V LuomaP R Ylöstalo
Jan 1, 1981·Developmental Pharmacology and Therapeutics·G M Pacifici, A Rane
Jun 1, 1982·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A M SymonsD V Parke
Oct 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·A P NarangV S Mathur
Jul 1, 1981·Biochemical Pharmacology·G PolidoroG Federici
Jan 1, 1980·Journal of Pharmaceutical Sciences·D C BloedowJ C Hargrove
Mar 1, 1980·Clinical Pharmacology and Therapeutics·D J GreenblattR I Shader
Aug 1, 1980·Clinical Pharmacology and Therapeutics·M DeanG Levy
Jan 1, 1980·Pharmacology & Therapeutics·B KrauerF E Hytten
Jan 1, 1981·Chemotherapy·I AmonC Mohr
Jul 1, 1958·Quarterly Journal of Experimental Physiology and Cognate Medical Sciences·G H LATHE, M WALKER
Apr 1, 1962·The Journal of Clinical Investigation·B COMBES, G S STAKELUM
Aug 1, 1963·American Journal of Obstetrics and Gynecology·J E KING, R F BECKER
Nov 1, 1963·Archives of Biochemistry and Biophysics·D Y HSIAR M DOWBEN

❮ Previous
Next ❯

Citations

Jan 1, 1987·Pharmacology & Therapeutics·E Perucca
Jul 1, 1993·Toxicology Letters·H AshourA Khodair
Jun 17, 2009·World Journal of Emergency Surgery : WJES·J KellyWo Kirwan
Jul 1, 1992·Toxicology in Vitro : an International Journal Published in Association with BIBRA·N G PalmenP T Henderson
Jan 1, 1987·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J A HolmeB Trygg
Feb 1, 1987·Journal of Clinical Pharmacology·R A Jordan, T F Woolf
Oct 1, 2016·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Ioannis ChristakisStephen Bloom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.